To prepare your audiology practice for sale in 2026, run a 36-month readiness plan that lifts adjusted EBITDA above $750,000, cleans third-party administrator (TPA) contribution margin, tightens hearing aid inventory turns to 6x or better, documents payer mix, and locks in audiologist retention agreements before the letter of intent. Practices that hit those four benchmarks typically transact at 5.0x to 9.0x adjusted EBITDA to strategic hearing aid chains, private equity roll-ups, and, in some markets, ENT platforms. Practices that skip the prep sell at 3.0x to 4.5x, or fail to close.

The 36-month audiology exit plan at a glance

Sellers who prepare 36 months out capture the widest buyer pool and the highest multiples. Months 36 to 25 fix operational leaks and payer mix. Months 24 to 13 build financial history a buyer’s quality-of-earnings team can defend. Months 12 to 0 run the marketed process. Skipping the first 24 months is what forces a 3.0x to 4.5x outcome instead of 6.5x to 9.0x.

The economics of a modern audiology practice

An audiology practice is a hybrid clinical-and-retail business. Diagnostic revenue is small and payer-dependent, while hearing aid device sales carry the practice. In 2024, US hearing aid unit shipments hit approximately 4.7 million units, of which the Veterans Administration alone accounted for roughly 20 percent, per the Hearing Industry Association (HIA) data reported by the American Academy of Audiology. Average retail per aid ranges roughly $2,300 to $3,500 in private practice, with cost of goods 30 to 45 percent depending on manufacturer, volume tier, and TPA contract.

Where the margin actually lives

Private-pay premium fittings drive the highest contribution margin. TPA-directed fittings (TruHearing, UnitedHealthcare Hearing, HearUSA-network Medicare Advantage plans) can compress gross margin per aid by 30 to 55 percent versus private pay. Buyers model contribution margin per fitting, not gross revenue. A practice with $3.2M revenue and 55 percent TPA volume can carry lower adjusted EBITDA than one with $2.4M revenue and 20 percent TPA volume.

Direct-to-consumer and OTC disruption

The FDA final rule of August 17, 2022, effective October 17, 2022, created an over-the-counter (OTC) hearing aid category for adults with perceived mild-to-moderate hearing loss. Direct-to-consumer entrants (Jabra Enhance, Sony CRE, Lexie, Eargo) took a growing but still minority share by 2025 per Audiology Research industry surveys and coverage tracked by the ENT and Audiology News. Independent practices that lean into audiological services, real-ear measurement, and higher-severity fittings typically defend margin. Buyers ask for service-mix data going back at least 24 months, so start tagging encounter types early. The NIDCD hearing loss statistics report 15 percent of American adults (37.5 million) have some trouble hearing, which sizes the underlying demand pool.

Who is buying audiology practices in 2026

The active-buyer universe splits into four buckets: manufacturer-owned retail chains, private-equity backed platforms, ENT groups with an audiology arm, and other independent audiologists funded by SBA loans. The lower-middle-market M&A advisory lens matters here because the buyer bucket dictates deal structure, rollover expectations, and multiple.

The current strategic roll-up landscape

The market has consolidated in three waves. Amplifon acquired Miracle-Ear via the completion of the Miracle-Ear transaction in April 2015. Sonova operates Connect Hearing globally and supplies Costco Hearing Aid Centers per Sonova's annual reports. Demant acquired the HearingLife US platform (formerly Hearing HealthCare, from HHM), consolidated under Demant Group Services, disclosed in Demant annual reports. GN Store Nord owns Beltone globally, per GN Store Nord annual reports. WS Audiology (Widex + Sivantos combined in March 2019) closed the acquisition of HearUSA in the United States per the WS Audiology 2020 announcement. Announcements confirmed by HearingTracker industry coverage.

Months 36 to 25: fix the operating platform

Twelve to 24 months of clean improvement history is the minimum a diligence team needs. In this window you address the four leaks that cost the most in multiple: TPA over-exposure, weak add-on attach rate, sloppy inventory, and staff dependency on the owner.

1. Rework your third-party administrator mix

Pull two years of encounter data by payer source. If TPA-directed fittings exceed 40 percent, model contribution margin under each contract. Renegotiate or exit contracts where contribution margin sits under $900 per aid. Add private-pay marketing (community events, physician referral, patient-of-record recall) to shift mix. Buyers pay premiums for practices where TPA share is 25 percent or less, per common private-equity heuristics disclosed in transactional case studies.

2. Real-ear measurement and service revenue

Real-ear measurement (REM) with probe-microphone verification is the American Academy of Audiology best-practice standard and is required for insurance audit defensibility. Practices that document REM on 90 percent-plus of fittings show lower return-for-credit rates. Charge for hearing assessments and aural rehabilitation as separately billable services under CMS Physician Fee Schedule CPT codes 92557, 92588, 92626, 92627.

3. Attach rate on tinnitus, custom molds, and accessories

Track and lift attach rate on tinnitus management, custom earmolds, and remote-microphone or streaming accessories. A 10-point lift in accessory attach can add $150,000 to $300,000 of annual gross profit in a $3M revenue practice.

Months 24 to 13: build defensible EBITDA

Quality of earnings (QoE) work will re-cut everything a seller believes about profitability. This window is where you get ahead of it. See our quality of earnings report seller deep dive for the mechanics of pre-sale QoE.

4. Move to accrual accounting with GAAP inventory reserves

Move from cash to accrual under Generally Accepted Accounting Principles (GAAP) as codified by the FASB Accounting Standards Codification. Book hearing aid inventory at lower of cost or net realizable value under ASC 330. Discontinued models sitting more than 12 months should be reserved to zero. Undisclosed obsolete inventory is a common last-minute price cut.

5. Document every EBITDA add-back with backup

Owner audiologist compensation above fair-market value, personal auto lease, family payroll, one-time HVAC replacement, and pandemic-era Employee Retention Credit distortions all can be normalized. Attach paystubs, invoices, and contracts to every add-back. The IRS ERC guidance is the citation you want in the QoE binder for any ERC-related normalizations.

6. Tighten inventory turns to 6x or better

Hearing aid inventory turns of 4x or less signals sloppy purchasing and hidden obsolescence. Move toward vendor-managed inventory or drop-ship where the manufacturer contract allows. Sonova, Demant/Oticon, GN/ReSound, WS Audiology/Widex, and Starkey all offer varying vendor stocking programs. Document turnover math in the data room.

7. Fix owner dependency and management depth

If the selling audiologist is more than 40 percent of clinical revenue, buyers discount the multiple. Hire and credential associate audiologists 24 months before close. Move from owner-scheduled to hearing-instrument-specialist (HIS) support where state scope-of-practice allows, per each state licensing board.

Months 12 to 4: retention, PC compliance, and data room

By month 12 the fundamentals are set. This window is about locking in people and structure so the buyer inherits a business, not a personality.

8. Audiologist retention agreements

Buyers require key-employee retention agreements before signing an LOI. Structure two-year to three-year stay bonuses (10 to 25 percent of annual base) with clawback on early departure, plus non-compete or non-solicit terms aligned with state law. The US Department of Labor state wage rules and each state audiology licensing board dictate the enforceable structure. The FTC Non-Compete Clause Rule published April 23, 2024 was vacated on August 20, 2024 by the US District Court for the Northern District of Texas in Ryan LLC v. FTC (Case No. 3:24-cv-00986-E), and the Fifth Circuit Court of Appeals affirmed the vacatur on February 12, 2026. Enforceability now runs on state law: California, Minnesota, North Dakota, and Oklahoma broadly ban employee non-competes; other states enforce reasonable scope and duration.

9. Professional corporation, non-audiologist ownership, and MSO structures

Many states restrict audiology practice ownership to licensed audiologists under professional corporation (PC) statutes. Buyers not licensed as audiologists (private equity, non-audiologist chains) transact through a management services organization (MSO) that owns operational assets and contracts with a friendly-PC that holds the license and employs the clinicians. The National Council of State Boards of Examiners for Audiology and Speech-Language Pathology maintains state-by-state licensure links; check corporate practice statutes with local health-care counsel. Practices in restrictive states (California, New York, Texas among them for various health professions) typically need the MSO/PC split executed before close.

10. Insurance credentialing and Medicare enrollment

Confirm active Medicare Provider Enrollment (CMS-855I / CMS-855B) for the practice entity and every audiologist. Verify National Provider Identifiers (NPIs) via the CMS NPI Registry and confirm scope-of-practice with the American Speech-Language-Hearing Association (ASHA) scope of practice. Credentialing with Medicare Advantage plans, TruHearing, Amplifon Hearing Health Care networks, and top commercial payers should be current with expiration dates tabulated. Buyers require assignability review or new enrollment for the buyer entity, which can take 90 to 180 days.

11. Build the data room

Standard M&A data room, plus audiology-specific artifacts: manufacturer contracts and rebate schedules, TPA contracts, insurance credentialing status, controlled-substance exposure (typically none, but confirm), state licensure certificates, HIPAA policies and last risk assessment per HHS HIPAA Security Rule, OSHA recordkeeping logs, real-ear measurement documentation sample, warranty and return-for-credit reporting from manufacturers. See our due diligence checklist for the general framework and add these audiology-specific items on top.

Months 3 to 0: run the marketed process

By month three, engage sell-side advisors, build the confidential information memorandum (CIM), and launch the process. A properly run investment banking process creates competitive tension across the buyer pool.

12. Buyer outreach and NDAs

Target 15 to 40 buyers spanning strategic chains, PE platforms, and ENT groups. Confidentiality is critical: patients, staff, and payers rarely know a sale is happening until close. Include operational identifiers only after signed NDA.

13. Letter of intent and exclusivity

The LOI locks price, structure, working capital peg, escrow, rollover, employment terms, and exclusivity (typically 60 to 90 days). See our seller-side letter of intent template guide for the terms sellers commonly negotiate before signing.

14. Diligence and close

Legal, financial, HR, IT, HIPAA/security, and payer credentialing diligence run in parallel. Escrow (10 to 15 percent), rep-and-warranty insurance (increasingly common on deals above $10M enterprise value), and a working-capital true-up close out the negotiation. Wire and stock consideration hit on close day. Post-close, the selling audiologist typically stays 12 to 36 months as clinical director.

What multiple can you actually get?

Adjusted EBITDA multiples for audiology practices in 2024 through mid-2026 have ranged 5.0x to 9.0x based on transaction data reported by industry brokerages and PE-backed platforms, consistent with health-care services multiples tracked by GF Data and reporting from PitchBook 2025 annual US PE breakdown. Size is the single largest driver, followed by TPA exposure and payer mix.

Practices with 60 percent-plus private-pay revenue, a clean PC/MSO structure, and audiologist retention agreements typically transact at the top of their band. See our M&A advisor fees guide for how sell-side economics interact with these multiples.

Tax structure and post-sale planning

Most audiology practice sales close as asset sales rather than stock/equity sales, primarily because buyers want a stepped-up basis in tangible assets and goodwill amortizable over 15 years under Section 197 of the Internal Revenue Code. Sellers typically negotiate purchase-price allocations that maximize long-term capital-gain treatment on goodwill and minimize ordinary-income allocation on personal goodwill and non-competes, per IRS Form 8594 instructions governing allocation of purchase price in an applicable asset acquisition.

Qualified Small Business Stock (QSBS) under IRC Section 1202 generally does not apply to audiology practices because Section 1202(e)(3) excludes any trade or business involving the performance of health services. That exclusion is not eliminated by any change through the effective date of this article. Confirm your specific structure with tax counsel. Post-sale, our guides on wealth management after a business sale cover diversification and liquidity planning after close.

Five common mistakes that cost multiples

1. Waiting until the owner wants to retire. Six-month timelines force a shallow buyer pool and typically 1.5 to 2.5 turns of multiple compression.
2. Ignoring TPA contribution margin. Sellers focused on top-line revenue miss that certain TPA contracts destroy contribution margin. Buyers do not.
3. Under-reserving obsolete inventory. Diligence often catches $50,000 to $200,000 of obsolete hearing aids that owners carried on the balance sheet at cost.
4. Skipping key-employee retention. A star associate audiologist quitting mid-diligence can drop enterprise value 15 to 25 percent overnight.
5. DIY sale without competing bids. Owners who take the first inbound offer typically leave 1.0 to 2.5 turns of multiple on the table versus a marketed process.

Frequently asked questions

How much is my audiology practice worth in 2026?

Most audiology practices in 2026 transact at 5.0x to 9.0x adjusted EBITDA, with size, payer mix, TPA exposure, and audiologist retention as the primary swing factors. Practices under $500,000 EBITDA typically fall to 3.0x to 4.5x with SBA-financed individual buyers. Practices above $2.5M EBITDA with clean structure often reach 7.0x to 9.0x with national strategics and PE platforms competing.

Who is buying audiology practices?

Four buyer types are active. Manufacturer-owned retail chains (Amplifon-Miracle Ear, Sonova Connect Hearing, Demant HearingLife, GN Store Nord Beltone, WS Audiology HearUSA) pay 5.5x to 8.5x for strategic fit. PE-backed platforms pay 6.0x to 9.0x with rollover equity. ENT-audiology groups pay 5.0x to 7.5x for cross-referral synergy. Independent audiologist buyers with SBA loans pay 3.5x to 5.5x on smaller deals.

Can a non-audiologist own an audiology practice?

Many states restrict audiology-practice ownership to licensed audiologists under professional corporation statutes, which means non-audiologist buyers typically transact through a management services organization (MSO) that owns the operating assets and contracts with a friendly professional corporation that employs the audiologists. State corporate-practice rules vary. Confirm the structure with local health-care counsel before signing an LOI.

What is the typical multiple for an audiology practice?

Adjusted EBITDA multiples for audiology practices range 5.0x to 9.0x in 2024 through mid-2026 based on transactions reported by industry brokerages and PE-backed platforms. Size drives the largest single component. TPA exposure, payer mix, PC compliance, and audiologist retention shift the number within the band for a given practice.

How long should I prepare before selling my audiology practice?

36 months is the target for practices seeking the top of the multiple range. That window is enough time to renegotiate TPA contracts, shift payer mix, tighten inventory turns to 6x or better, book two clean fiscal years on accrual accounting, hire and retain associate audiologists, and complete PC/MSO restructuring where required. Sellers with a six-month runway typically transact at 1.5 to 2.5 turns lower.

Does QSBS Section 1202 apply to my audiology practice?

QSBS Section 1202 generally does not apply because Section 1202(e)(3) excludes any trade or business involving the performance of health services. That exclusion covers audiology in most fact patterns. Speak with tax counsel about specific carve-outs. Asset sales with careful purchase-price allocation typically offer better tax outcomes than trying to force QSBS treatment.

What documents belong in my data room?

Standard financials plus these audiology-specific artifacts: manufacturer purchase and rebate contracts, TPA contracts with contribution-margin backup, insurance credentialing status and expirations, HIPAA policies and most recent risk assessment, OSHA logs, state audiology licensure certificates, real-ear measurement documentation samples, and warranty and return-for-credit reporting from manufacturers going back 24 months.

Should I use a broker or an M&A advisor?

Sub-$5M enterprise value transactions often use a business broker. Deals above $5M enterprise value typically use a sell-side M&A advisor who runs a competitive marketed process. Our M&A advisor versus business broker comparison covers fee structure, buyer network, and process depth differences.

Where to go next

If you are 6 to 36 months from an audiology practice exit, start with a readiness diagnostic. CT Acquisitions runs sell-side processes for lower-middle-market health-care service businesses, including audiology, dental, veterinary, and physical therapy. Reach out to schedule a confidential conversation. See also our prepare your business for sale hub for parallel playbooks in adjacent verticals, or the exit planning hub for broader owner-transition planning.